Citadel Advisors’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8M Buy
1,436,201
+912,442
+174% +$13.8M 0.01% 2357
2025
Q4
$9.44M Buy
523,759
+33,547
+7% +$602K 0.01% 3324
2025
Q3
$9.08M Buy
490,212
+229,503
+88% +$3.61M 0.01% 3417
2025
Q2
$4.17M Sell
260,709
-20,309
-7% -$362K ﹤0.01% 4421
2025
Q1
$5.46M Sell
281,018
-343,461
-55% -$7.23M 0.01% 3727
2024
Q4
$13.8M Sell
624,479
-219,174
-26% -$4.22M 0.01% 2580
2024
Q3
$14.2M Buy
843,653
+319,674
+61% +$4.74M 0.01% 2445
2024
Q2
$6.26M Sell
523,979
-178,683
-25% -$2M 0.01% 3407
2024
Q1
$7.79M Buy
702,662
+185,764
+36% +$1.9M 0.01% 3287
2023
Q4
$4.48M Buy
516,898
+329,109
+175% +$2.56M ﹤0.01% 3954
2023
Q3
$1.44M Sell
187,789
-14,518
-7% -$109K ﹤0.01% 5854
2023
Q2
$1.46M Buy
202,307
+54,361
+37% +$317K ﹤0.01% 5727
2023
Q1
$901K Buy
147,946
+56,216
+61% +$305K ﹤0.01% 7007
2022
Q4
$400K Sell
91,730
-32,076
-26% -$143K ﹤0.01% 8717
2022
Q3
$486K Sell
123,806
-42,956
-26% -$215K ﹤0.01% 8512
2022
Q2
$850K Sell
166,762
-3,491
-2% -$18.2K ﹤0.01% 7400
2022
Q1
$1.09M Buy
170,253
+142,863
+522% +$947K ﹤0.01% 7500
2021
Q4
$220K Buy
27,390
+6,470
+31% +$60.9K ﹤0.01% 11642
2021
Q3
$194K Buy
+20,920
New +$219K ﹤0.01% 12027

Other funds holding CLBT